Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001140361-21-036904
Filing Date
2021-11-08
Accepted
2021-11-08 06:15:27
Documents
4
Group Members
GEORGE R. ROBERTSHENRY R. KRAVISKKR & CO. INC.KKR GROUP HOLDINGS CORP.KKR GROUP PARTNERSHIP L.P.KKR MANAGEMENT LLPKKR PHORM INVESTORS GP LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10030499_sc13da.htm SC 13D/A 298656
2 EXHIBIT H brhc10030499_ex99-h.htm EX-99.H 159909
3 EXHIBIT I brhc10030499_ex99-i.htm EX-99.I 117023
4 EXHIBIT J brhc10030499_ex99-j.htm EX-99.J 76338
  Complete submission text file 0001140361-21-036904.txt   653804
Mailing Address 75 CASTILIAN DRIVE GOLETA CA 93117
Business Address 75 CASTILIAN DRIVE GOLETA CA 93117 805-456-1300
Transphorm, Inc. (Subject) CIK: 0001715768 (see all company filings)

EIN.: 821858829 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-90877 | Film No.: 211386399
SIC: 3674 Semiconductors & Related Devices

Mailing Address C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 30 HUDSON YARDS NEW YORK NY 10001
Business Address C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 30 HUDSON YARDS NEW YORK NY 10001 212-230-9742
KKR Phorm Investors L.P. (Filed by) CIK: 0001806548 (see all company filings)

EIN.: 473998300 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A